Pharma & Healthcare
Global C-C Chemokine Receptor Type 4 Market Research Report 2025
- Sep 04, 25
- ID: 482897
- Pages: 79
- Figures: 77
- Views: 16
The global market for C-C Chemokine Receptor Type 4 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for C-C Chemokine Receptor Type 4 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for C-C Chemokine Receptor Type 4 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for C-C Chemokine Receptor Type 4 in Immunology is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of C-C Chemokine Receptor Type 4 include Affitech A/S, AstraZeneca Plc, ChemoCentryx Inc, Corion Biotech Srl, FLX Bio Inc, Globavir Biosciences Inc, Kyowa Hakko Kirin Co Ltd, Ono Pharmaceutical Co Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for C-C Chemokine Receptor Type 4, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding C-C Chemokine Receptor Type 4.
The C-C Chemokine Receptor Type 4 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global C-C Chemokine Receptor Type 4 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the C-C Chemokine Receptor Type 4 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Affitech A/S
AstraZeneca Plc
ChemoCentryx Inc
Corion Biotech Srl
FLX Bio Inc
Globavir Biosciences Inc
Kyowa Hakko Kirin Co Ltd
Ono Pharmaceutical Co Ltd
Segment by Type
CCX-6239
E-0001163
GBV-3019
K-777
Others
Segment by Application
Immunology
Central Nervous System
Mycosis Fungoides
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of C-C Chemokine Receptor Type 4 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for C-C Chemokine Receptor Type 4 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for C-C Chemokine Receptor Type 4 is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for C-C Chemokine Receptor Type 4 in Immunology is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of C-C Chemokine Receptor Type 4 include Affitech A/S, AstraZeneca Plc, ChemoCentryx Inc, Corion Biotech Srl, FLX Bio Inc, Globavir Biosciences Inc, Kyowa Hakko Kirin Co Ltd, Ono Pharmaceutical Co Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for C-C Chemokine Receptor Type 4, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding C-C Chemokine Receptor Type 4.
The C-C Chemokine Receptor Type 4 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global C-C Chemokine Receptor Type 4 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the C-C Chemokine Receptor Type 4 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Affitech A/S
AstraZeneca Plc
ChemoCentryx Inc
Corion Biotech Srl
FLX Bio Inc
Globavir Biosciences Inc
Kyowa Hakko Kirin Co Ltd
Ono Pharmaceutical Co Ltd
Segment by Type
CCX-6239
E-0001163
GBV-3019
K-777
Others
Segment by Application
Immunology
Central Nervous System
Mycosis Fungoides
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of C-C Chemokine Receptor Type 4 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global C-C Chemokine Receptor Type 4 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CCX-6239
1.2.3 E-0001163
1.2.4 GBV-3019
1.2.5 K-777
1.2.6 Others
1.3 Market by Application
1.3.1 Global C-C Chemokine Receptor Type 4 Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunology
1.3.3 Central Nervous System
1.3.4 Mycosis Fungoides
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global C-C Chemokine Receptor Type 4 Market Perspective (2020-2031)
2.2 Global C-C Chemokine Receptor Type 4 Growth Trends by Region
2.2.1 Global C-C Chemokine Receptor Type 4 Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 C-C Chemokine Receptor Type 4 Historic Market Size by Region (2020-2025)
2.2.3 C-C Chemokine Receptor Type 4 Forecasted Market Size by Region (2026-2031)
2.3 C-C Chemokine Receptor Type 4 Market Dynamics
2.3.1 C-C Chemokine Receptor Type 4 Industry Trends
2.3.2 C-C Chemokine Receptor Type 4 Market Drivers
2.3.3 C-C Chemokine Receptor Type 4 Market Challenges
2.3.4 C-C Chemokine Receptor Type 4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top C-C Chemokine Receptor Type 4 Players by Revenue
3.1.1 Global Top C-C Chemokine Receptor Type 4 Players by Revenue (2020-2025)
3.1.2 Global C-C Chemokine Receptor Type 4 Revenue Market Share by Players (2020-2025)
3.2 Global C-C Chemokine Receptor Type 4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by C-C Chemokine Receptor Type 4 Revenue
3.4 Global C-C Chemokine Receptor Type 4 Market Concentration Ratio
3.4.1 Global C-C Chemokine Receptor Type 4 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by C-C Chemokine Receptor Type 4 Revenue in 2024
3.5 Global Key Players of C-C Chemokine Receptor Type 4 Head office and Area Served
3.6 Global Key Players of C-C Chemokine Receptor Type 4, Product and Application
3.7 Global Key Players of C-C Chemokine Receptor Type 4, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 C-C Chemokine Receptor Type 4 Breakdown Data by Type
4.1 Global C-C Chemokine Receptor Type 4 Historic Market Size by Type (2020-2025)
4.2 Global C-C Chemokine Receptor Type 4 Forecasted Market Size by Type (2026-2031)
5 C-C Chemokine Receptor Type 4 Breakdown Data by Application
5.1 Global C-C Chemokine Receptor Type 4 Historic Market Size by Application (2020-2025)
5.2 Global C-C Chemokine Receptor Type 4 Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America C-C Chemokine Receptor Type 4 Market Size (2020-2031)
6.2 North America C-C Chemokine Receptor Type 4 Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America C-C Chemokine Receptor Type 4 Market Size by Country (2020-2025)
6.4 North America C-C Chemokine Receptor Type 4 Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe C-C Chemokine Receptor Type 4 Market Size (2020-2031)
7.2 Europe C-C Chemokine Receptor Type 4 Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe C-C Chemokine Receptor Type 4 Market Size by Country (2020-2025)
7.4 Europe C-C Chemokine Receptor Type 4 Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size (2020-2031)
8.2 Asia-Pacific C-C Chemokine Receptor Type 4 Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Region (2020-2025)
8.4 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America C-C Chemokine Receptor Type 4 Market Size (2020-2031)
9.2 Latin America C-C Chemokine Receptor Type 4 Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America C-C Chemokine Receptor Type 4 Market Size by Country (2020-2025)
9.4 Latin America C-C Chemokine Receptor Type 4 Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size (2020-2031)
10.2 Middle East & Africa C-C Chemokine Receptor Type 4 Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2020-2025)
10.4 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Affitech A/S
11.1.1 Affitech A/S Company Details
11.1.2 Affitech A/S Business Overview
11.1.3 Affitech A/S C-C Chemokine Receptor Type 4 Introduction
11.1.4 Affitech A/S Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025)
11.1.5 Affitech A/S Recent Development
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Details
11.2.2 AstraZeneca Plc Business Overview
11.2.3 AstraZeneca Plc C-C Chemokine Receptor Type 4 Introduction
11.2.4 AstraZeneca Plc Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025)
11.2.5 AstraZeneca Plc Recent Development
11.3 ChemoCentryx Inc
11.3.1 ChemoCentryx Inc Company Details
11.3.2 ChemoCentryx Inc Business Overview
11.3.3 ChemoCentryx Inc C-C Chemokine Receptor Type 4 Introduction
11.3.4 ChemoCentryx Inc Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025)
11.3.5 ChemoCentryx Inc Recent Development
11.4 Corion Biotech Srl
11.4.1 Corion Biotech Srl Company Details
11.4.2 Corion Biotech Srl Business Overview
11.4.3 Corion Biotech Srl C-C Chemokine Receptor Type 4 Introduction
11.4.4 Corion Biotech Srl Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025)
11.4.5 Corion Biotech Srl Recent Development
11.5 FLX Bio Inc
11.5.1 FLX Bio Inc Company Details
11.5.2 FLX Bio Inc Business Overview
11.5.3 FLX Bio Inc C-C Chemokine Receptor Type 4 Introduction
11.5.4 FLX Bio Inc Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025)
11.5.5 FLX Bio Inc Recent Development
11.6 Globavir Biosciences Inc
11.6.1 Globavir Biosciences Inc Company Details
11.6.2 Globavir Biosciences Inc Business Overview
11.6.3 Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Introduction
11.6.4 Globavir Biosciences Inc Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025)
11.6.5 Globavir Biosciences Inc Recent Development
11.7 Kyowa Hakko Kirin Co Ltd
11.7.1 Kyowa Hakko Kirin Co Ltd Company Details
11.7.2 Kyowa Hakko Kirin Co Ltd Business Overview
11.7.3 Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Introduction
11.7.4 Kyowa Hakko Kirin Co Ltd Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025)
11.7.5 Kyowa Hakko Kirin Co Ltd Recent Development
11.8 Ono Pharmaceutical Co Ltd
11.8.1 Ono Pharmaceutical Co Ltd Company Details
11.8.2 Ono Pharmaceutical Co Ltd Business Overview
11.8.3 Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Introduction
11.8.4 Ono Pharmaceutical Co Ltd Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025)
11.8.5 Ono Pharmaceutical Co Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global C-C Chemokine Receptor Type 4 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CCX-6239
1.2.3 E-0001163
1.2.4 GBV-3019
1.2.5 K-777
1.2.6 Others
1.3 Market by Application
1.3.1 Global C-C Chemokine Receptor Type 4 Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Immunology
1.3.3 Central Nervous System
1.3.4 Mycosis Fungoides
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global C-C Chemokine Receptor Type 4 Market Perspective (2020-2031)
2.2 Global C-C Chemokine Receptor Type 4 Growth Trends by Region
2.2.1 Global C-C Chemokine Receptor Type 4 Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 C-C Chemokine Receptor Type 4 Historic Market Size by Region (2020-2025)
2.2.3 C-C Chemokine Receptor Type 4 Forecasted Market Size by Region (2026-2031)
2.3 C-C Chemokine Receptor Type 4 Market Dynamics
2.3.1 C-C Chemokine Receptor Type 4 Industry Trends
2.3.2 C-C Chemokine Receptor Type 4 Market Drivers
2.3.3 C-C Chemokine Receptor Type 4 Market Challenges
2.3.4 C-C Chemokine Receptor Type 4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top C-C Chemokine Receptor Type 4 Players by Revenue
3.1.1 Global Top C-C Chemokine Receptor Type 4 Players by Revenue (2020-2025)
3.1.2 Global C-C Chemokine Receptor Type 4 Revenue Market Share by Players (2020-2025)
3.2 Global C-C Chemokine Receptor Type 4 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by C-C Chemokine Receptor Type 4 Revenue
3.4 Global C-C Chemokine Receptor Type 4 Market Concentration Ratio
3.4.1 Global C-C Chemokine Receptor Type 4 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by C-C Chemokine Receptor Type 4 Revenue in 2024
3.5 Global Key Players of C-C Chemokine Receptor Type 4 Head office and Area Served
3.6 Global Key Players of C-C Chemokine Receptor Type 4, Product and Application
3.7 Global Key Players of C-C Chemokine Receptor Type 4, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 C-C Chemokine Receptor Type 4 Breakdown Data by Type
4.1 Global C-C Chemokine Receptor Type 4 Historic Market Size by Type (2020-2025)
4.2 Global C-C Chemokine Receptor Type 4 Forecasted Market Size by Type (2026-2031)
5 C-C Chemokine Receptor Type 4 Breakdown Data by Application
5.1 Global C-C Chemokine Receptor Type 4 Historic Market Size by Application (2020-2025)
5.2 Global C-C Chemokine Receptor Type 4 Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America C-C Chemokine Receptor Type 4 Market Size (2020-2031)
6.2 North America C-C Chemokine Receptor Type 4 Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America C-C Chemokine Receptor Type 4 Market Size by Country (2020-2025)
6.4 North America C-C Chemokine Receptor Type 4 Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe C-C Chemokine Receptor Type 4 Market Size (2020-2031)
7.2 Europe C-C Chemokine Receptor Type 4 Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe C-C Chemokine Receptor Type 4 Market Size by Country (2020-2025)
7.4 Europe C-C Chemokine Receptor Type 4 Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size (2020-2031)
8.2 Asia-Pacific C-C Chemokine Receptor Type 4 Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Region (2020-2025)
8.4 Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America C-C Chemokine Receptor Type 4 Market Size (2020-2031)
9.2 Latin America C-C Chemokine Receptor Type 4 Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America C-C Chemokine Receptor Type 4 Market Size by Country (2020-2025)
9.4 Latin America C-C Chemokine Receptor Type 4 Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size (2020-2031)
10.2 Middle East & Africa C-C Chemokine Receptor Type 4 Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2020-2025)
10.4 Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Affitech A/S
11.1.1 Affitech A/S Company Details
11.1.2 Affitech A/S Business Overview
11.1.3 Affitech A/S C-C Chemokine Receptor Type 4 Introduction
11.1.4 Affitech A/S Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025)
11.1.5 Affitech A/S Recent Development
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Details
11.2.2 AstraZeneca Plc Business Overview
11.2.3 AstraZeneca Plc C-C Chemokine Receptor Type 4 Introduction
11.2.4 AstraZeneca Plc Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025)
11.2.5 AstraZeneca Plc Recent Development
11.3 ChemoCentryx Inc
11.3.1 ChemoCentryx Inc Company Details
11.3.2 ChemoCentryx Inc Business Overview
11.3.3 ChemoCentryx Inc C-C Chemokine Receptor Type 4 Introduction
11.3.4 ChemoCentryx Inc Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025)
11.3.5 ChemoCentryx Inc Recent Development
11.4 Corion Biotech Srl
11.4.1 Corion Biotech Srl Company Details
11.4.2 Corion Biotech Srl Business Overview
11.4.3 Corion Biotech Srl C-C Chemokine Receptor Type 4 Introduction
11.4.4 Corion Biotech Srl Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025)
11.4.5 Corion Biotech Srl Recent Development
11.5 FLX Bio Inc
11.5.1 FLX Bio Inc Company Details
11.5.2 FLX Bio Inc Business Overview
11.5.3 FLX Bio Inc C-C Chemokine Receptor Type 4 Introduction
11.5.4 FLX Bio Inc Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025)
11.5.5 FLX Bio Inc Recent Development
11.6 Globavir Biosciences Inc
11.6.1 Globavir Biosciences Inc Company Details
11.6.2 Globavir Biosciences Inc Business Overview
11.6.3 Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Introduction
11.6.4 Globavir Biosciences Inc Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025)
11.6.5 Globavir Biosciences Inc Recent Development
11.7 Kyowa Hakko Kirin Co Ltd
11.7.1 Kyowa Hakko Kirin Co Ltd Company Details
11.7.2 Kyowa Hakko Kirin Co Ltd Business Overview
11.7.3 Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Introduction
11.7.4 Kyowa Hakko Kirin Co Ltd Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025)
11.7.5 Kyowa Hakko Kirin Co Ltd Recent Development
11.8 Ono Pharmaceutical Co Ltd
11.8.1 Ono Pharmaceutical Co Ltd Company Details
11.8.2 Ono Pharmaceutical Co Ltd Business Overview
11.8.3 Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Introduction
11.8.4 Ono Pharmaceutical Co Ltd Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025)
11.8.5 Ono Pharmaceutical Co Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global C-C Chemokine Receptor Type 4 Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CCX-6239
Table 3. Key Players of E-0001163
Table 4. Key Players of GBV-3019
Table 5. Key Players of K-777
Table 6. Key Players of Others
Table 7. Global C-C Chemokine Receptor Type 4 Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global C-C Chemokine Receptor Type 4 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global C-C Chemokine Receptor Type 4 Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global C-C Chemokine Receptor Type 4 Market Share by Region (2020-2025)
Table 11. Global C-C Chemokine Receptor Type 4 Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global C-C Chemokine Receptor Type 4 Market Share by Region (2026-2031)
Table 13. C-C Chemokine Receptor Type 4 Market Trends
Table 14. C-C Chemokine Receptor Type 4 Market Drivers
Table 15. C-C Chemokine Receptor Type 4 Market Challenges
Table 16. C-C Chemokine Receptor Type 4 Market Restraints
Table 17. Global C-C Chemokine Receptor Type 4 Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global C-C Chemokine Receptor Type 4 Market Share by Players (2020-2025)
Table 19. Global Top C-C Chemokine Receptor Type 4 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C-C Chemokine Receptor Type 4 as of 2024)
Table 20. Ranking of Global Top C-C Chemokine Receptor Type 4 Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by C-C Chemokine Receptor Type 4 Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of C-C Chemokine Receptor Type 4, Headquarters and Area Served
Table 23. Global Key Players of C-C Chemokine Receptor Type 4, Product and Application
Table 24. Global Key Players of C-C Chemokine Receptor Type 4, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global C-C Chemokine Receptor Type 4 Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type (2020-2025)
Table 28. Global C-C Chemokine Receptor Type 4 Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type (2026-2031)
Table 30. Global C-C Chemokine Receptor Type 4 Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Application (2020-2025)
Table 32. Global C-C Chemokine Receptor Type 4 Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Application (2026-2031)
Table 34. North America C-C Chemokine Receptor Type 4 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America C-C Chemokine Receptor Type 4 Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America C-C Chemokine Receptor Type 4 Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe C-C Chemokine Receptor Type 4 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe C-C Chemokine Receptor Type 4 Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe C-C Chemokine Receptor Type 4 Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America C-C Chemokine Receptor Type 4 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America C-C Chemokine Receptor Type 4 Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America C-C Chemokine Receptor Type 4 Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2026-2031) & (US$ Million)
Table 49. Affitech A/S Company Details
Table 50. Affitech A/S Business Overview
Table 51. Affitech A/S C-C Chemokine Receptor Type 4 Product
Table 52. Affitech A/S Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025) & (US$ Million)
Table 53. Affitech A/S Recent Development
Table 54. AstraZeneca Plc Company Details
Table 55. AstraZeneca Plc Business Overview
Table 56. AstraZeneca Plc C-C Chemokine Receptor Type 4 Product
Table 57. AstraZeneca Plc Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025) & (US$ Million)
Table 58. AstraZeneca Plc Recent Development
Table 59. ChemoCentryx Inc Company Details
Table 60. ChemoCentryx Inc Business Overview
Table 61. ChemoCentryx Inc C-C Chemokine Receptor Type 4 Product
Table 62. ChemoCentryx Inc Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025) & (US$ Million)
Table 63. ChemoCentryx Inc Recent Development
Table 64. Corion Biotech Srl Company Details
Table 65. Corion Biotech Srl Business Overview
Table 66. Corion Biotech Srl C-C Chemokine Receptor Type 4 Product
Table 67. Corion Biotech Srl Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025) & (US$ Million)
Table 68. Corion Biotech Srl Recent Development
Table 69. FLX Bio Inc Company Details
Table 70. FLX Bio Inc Business Overview
Table 71. FLX Bio Inc C-C Chemokine Receptor Type 4 Product
Table 72. FLX Bio Inc Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025) & (US$ Million)
Table 73. FLX Bio Inc Recent Development
Table 74. Globavir Biosciences Inc Company Details
Table 75. Globavir Biosciences Inc Business Overview
Table 76. Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Product
Table 77. Globavir Biosciences Inc Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025) & (US$ Million)
Table 78. Globavir Biosciences Inc Recent Development
Table 79. Kyowa Hakko Kirin Co Ltd Company Details
Table 80. Kyowa Hakko Kirin Co Ltd Business Overview
Table 81. Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Product
Table 82. Kyowa Hakko Kirin Co Ltd Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025) & (US$ Million)
Table 83. Kyowa Hakko Kirin Co Ltd Recent Development
Table 84. Ono Pharmaceutical Co Ltd Company Details
Table 85. Ono Pharmaceutical Co Ltd Business Overview
Table 86. Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Product
Table 87. Ono Pharmaceutical Co Ltd Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025) & (US$ Million)
Table 88. Ono Pharmaceutical Co Ltd Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
Table 92. Authors List of This Report
List of Figures
Figure 1. C-C Chemokine Receptor Type 4 Picture
Figure 2. Global C-C Chemokine Receptor Type 4 Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global C-C Chemokine Receptor Type 4 Market Share by Type: 2024 VS 2031
Figure 4. CCX-6239 Features
Figure 5. E-0001163 Features
Figure 6. GBV-3019 Features
Figure 7. K-777 Features
Figure 8. Others Features
Figure 9. Global C-C Chemokine Receptor Type 4 Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global C-C Chemokine Receptor Type 4 Market Share by Application: 2024 VS 2031
Figure 11. Immunology Case Studies
Figure 12. Central Nervous System Case Studies
Figure 13. Mycosis Fungoides Case Studies
Figure 14. Others Case Studies
Figure 15. C-C Chemokine Receptor Type 4 Report Years Considered
Figure 16. Global C-C Chemokine Receptor Type 4 Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global C-C Chemokine Receptor Type 4 Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global C-C Chemokine Receptor Type 4 Market Share by Region: 2024 VS 2031
Figure 19. Global C-C Chemokine Receptor Type 4 Market Share by Players in 2024
Figure 20. Global Top C-C Chemokine Receptor Type 4 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C-C Chemokine Receptor Type 4 as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by C-C Chemokine Receptor Type 4 Revenue in 2024
Figure 22. North America C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America C-C Chemokine Receptor Type 4 Market Share by Country (2020-2031)
Figure 24. United States C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe C-C Chemokine Receptor Type 4 Market Share by Country (2020-2031)
Figure 28. Germany C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific C-C Chemokine Receptor Type 4 Market Share by Region (2020-2031)
Figure 36. China C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America C-C Chemokine Receptor Type 4 Market Share by Country (2020-2031)
Figure 44. Mexico C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa C-C Chemokine Receptor Type 4 Market Share by Country (2020-2031)
Figure 48. Turkey C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Affitech A/S Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2020-2025)
Figure 52. AstraZeneca Plc Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2020-2025)
Figure 53. ChemoCentryx Inc Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2020-2025)
Figure 54. Corion Biotech Srl Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2020-2025)
Figure 55. FLX Bio Inc Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2020-2025)
Figure 56. Globavir Biosciences Inc Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2020-2025)
Figure 57. Kyowa Hakko Kirin Co Ltd Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2020-2025)
Figure 58. Ono Pharmaceutical Co Ltd Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global C-C Chemokine Receptor Type 4 Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of CCX-6239
Table 3. Key Players of E-0001163
Table 4. Key Players of GBV-3019
Table 5. Key Players of K-777
Table 6. Key Players of Others
Table 7. Global C-C Chemokine Receptor Type 4 Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global C-C Chemokine Receptor Type 4 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global C-C Chemokine Receptor Type 4 Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global C-C Chemokine Receptor Type 4 Market Share by Region (2020-2025)
Table 11. Global C-C Chemokine Receptor Type 4 Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global C-C Chemokine Receptor Type 4 Market Share by Region (2026-2031)
Table 13. C-C Chemokine Receptor Type 4 Market Trends
Table 14. C-C Chemokine Receptor Type 4 Market Drivers
Table 15. C-C Chemokine Receptor Type 4 Market Challenges
Table 16. C-C Chemokine Receptor Type 4 Market Restraints
Table 17. Global C-C Chemokine Receptor Type 4 Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global C-C Chemokine Receptor Type 4 Market Share by Players (2020-2025)
Table 19. Global Top C-C Chemokine Receptor Type 4 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C-C Chemokine Receptor Type 4 as of 2024)
Table 20. Ranking of Global Top C-C Chemokine Receptor Type 4 Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by C-C Chemokine Receptor Type 4 Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of C-C Chemokine Receptor Type 4, Headquarters and Area Served
Table 23. Global Key Players of C-C Chemokine Receptor Type 4, Product and Application
Table 24. Global Key Players of C-C Chemokine Receptor Type 4, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global C-C Chemokine Receptor Type 4 Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type (2020-2025)
Table 28. Global C-C Chemokine Receptor Type 4 Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Type (2026-2031)
Table 30. Global C-C Chemokine Receptor Type 4 Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Application (2020-2025)
Table 32. Global C-C Chemokine Receptor Type 4 Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global C-C Chemokine Receptor Type 4 Revenue Market Share by Application (2026-2031)
Table 34. North America C-C Chemokine Receptor Type 4 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America C-C Chemokine Receptor Type 4 Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America C-C Chemokine Receptor Type 4 Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe C-C Chemokine Receptor Type 4 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe C-C Chemokine Receptor Type 4 Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe C-C Chemokine Receptor Type 4 Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America C-C Chemokine Receptor Type 4 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America C-C Chemokine Receptor Type 4 Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America C-C Chemokine Receptor Type 4 Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size by Country (2026-2031) & (US$ Million)
Table 49. Affitech A/S Company Details
Table 50. Affitech A/S Business Overview
Table 51. Affitech A/S C-C Chemokine Receptor Type 4 Product
Table 52. Affitech A/S Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025) & (US$ Million)
Table 53. Affitech A/S Recent Development
Table 54. AstraZeneca Plc Company Details
Table 55. AstraZeneca Plc Business Overview
Table 56. AstraZeneca Plc C-C Chemokine Receptor Type 4 Product
Table 57. AstraZeneca Plc Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025) & (US$ Million)
Table 58. AstraZeneca Plc Recent Development
Table 59. ChemoCentryx Inc Company Details
Table 60. ChemoCentryx Inc Business Overview
Table 61. ChemoCentryx Inc C-C Chemokine Receptor Type 4 Product
Table 62. ChemoCentryx Inc Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025) & (US$ Million)
Table 63. ChemoCentryx Inc Recent Development
Table 64. Corion Biotech Srl Company Details
Table 65. Corion Biotech Srl Business Overview
Table 66. Corion Biotech Srl C-C Chemokine Receptor Type 4 Product
Table 67. Corion Biotech Srl Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025) & (US$ Million)
Table 68. Corion Biotech Srl Recent Development
Table 69. FLX Bio Inc Company Details
Table 70. FLX Bio Inc Business Overview
Table 71. FLX Bio Inc C-C Chemokine Receptor Type 4 Product
Table 72. FLX Bio Inc Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025) & (US$ Million)
Table 73. FLX Bio Inc Recent Development
Table 74. Globavir Biosciences Inc Company Details
Table 75. Globavir Biosciences Inc Business Overview
Table 76. Globavir Biosciences Inc C-C Chemokine Receptor Type 4 Product
Table 77. Globavir Biosciences Inc Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025) & (US$ Million)
Table 78. Globavir Biosciences Inc Recent Development
Table 79. Kyowa Hakko Kirin Co Ltd Company Details
Table 80. Kyowa Hakko Kirin Co Ltd Business Overview
Table 81. Kyowa Hakko Kirin Co Ltd C-C Chemokine Receptor Type 4 Product
Table 82. Kyowa Hakko Kirin Co Ltd Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025) & (US$ Million)
Table 83. Kyowa Hakko Kirin Co Ltd Recent Development
Table 84. Ono Pharmaceutical Co Ltd Company Details
Table 85. Ono Pharmaceutical Co Ltd Business Overview
Table 86. Ono Pharmaceutical Co Ltd C-C Chemokine Receptor Type 4 Product
Table 87. Ono Pharmaceutical Co Ltd Revenue in C-C Chemokine Receptor Type 4 Business (2020-2025) & (US$ Million)
Table 88. Ono Pharmaceutical Co Ltd Recent Development
Table 89. Research Programs/Design for This Report
Table 90. Key Data Information from Secondary Sources
Table 91. Key Data Information from Primary Sources
Table 92. Authors List of This Report
List of Figures
Figure 1. C-C Chemokine Receptor Type 4 Picture
Figure 2. Global C-C Chemokine Receptor Type 4 Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global C-C Chemokine Receptor Type 4 Market Share by Type: 2024 VS 2031
Figure 4. CCX-6239 Features
Figure 5. E-0001163 Features
Figure 6. GBV-3019 Features
Figure 7. K-777 Features
Figure 8. Others Features
Figure 9. Global C-C Chemokine Receptor Type 4 Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global C-C Chemokine Receptor Type 4 Market Share by Application: 2024 VS 2031
Figure 11. Immunology Case Studies
Figure 12. Central Nervous System Case Studies
Figure 13. Mycosis Fungoides Case Studies
Figure 14. Others Case Studies
Figure 15. C-C Chemokine Receptor Type 4 Report Years Considered
Figure 16. Global C-C Chemokine Receptor Type 4 Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global C-C Chemokine Receptor Type 4 Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global C-C Chemokine Receptor Type 4 Market Share by Region: 2024 VS 2031
Figure 19. Global C-C Chemokine Receptor Type 4 Market Share by Players in 2024
Figure 20. Global Top C-C Chemokine Receptor Type 4 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C-C Chemokine Receptor Type 4 as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by C-C Chemokine Receptor Type 4 Revenue in 2024
Figure 22. North America C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America C-C Chemokine Receptor Type 4 Market Share by Country (2020-2031)
Figure 24. United States C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe C-C Chemokine Receptor Type 4 Market Share by Country (2020-2031)
Figure 28. Germany C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific C-C Chemokine Receptor Type 4 Market Share by Region (2020-2031)
Figure 36. China C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America C-C Chemokine Receptor Type 4 Market Share by Country (2020-2031)
Figure 44. Mexico C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa C-C Chemokine Receptor Type 4 Market Share by Country (2020-2031)
Figure 48. Turkey C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE C-C Chemokine Receptor Type 4 Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Affitech A/S Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2020-2025)
Figure 52. AstraZeneca Plc Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2020-2025)
Figure 53. ChemoCentryx Inc Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2020-2025)
Figure 54. Corion Biotech Srl Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2020-2025)
Figure 55. FLX Bio Inc Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2020-2025)
Figure 56. Globavir Biosciences Inc Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2020-2025)
Figure 57. Kyowa Hakko Kirin Co Ltd Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2020-2025)
Figure 58. Ono Pharmaceutical Co Ltd Revenue Growth Rate in C-C Chemokine Receptor Type 4 Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232